8669
0
Posted on Jan 19, 2005, 11 a.m.
By Bill Freeman
High levels of a blood protein called mannose-binding lectin (MBL) are associated with lower risk of heart attack, particularly among diabetics, report Saevardottir and colleagues. They suggest that measuring this protein in the bloodstream may help doctors decide if certain patients should receive additional treatments to decrease their heart attack risk, according to a study in the January 3rd issue of The Journal of Experimental Medicine.
High levels of a blood protein called mannose-binding lectin (MBL) are associated with lower risk of heart attack, particularly among diabetics, report Saevardottir and colleagues. They suggest that measuring this protein in the bloodstream may help doctors decide if certain patients should receive additional treatments to decrease their heart attack risk, according to a study in the January 3rd issue of The Journal of Experimental Medicine.
http://www.sciencedaily.com/releases/2005/01/050111170836.htm
http://www.sciencedaily.com/releases/2005/01/050111170836.htm
